$ML
MONEYLION INC.

2023 Q2 Form 10-Q Financial Statement

#000095017023019672 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $106.5M $93.67M $69.71M
YoY Change 21.98% 34.36% 110.43%
Cost Of Revenue $32.23M $29.80M $21.20M
YoY Change 9.68% 40.55% 114.12%
Gross Profit $74.31M $63.87M $48.51M
YoY Change 28.22% 31.66% 108.85%
Gross Profit Margin 69.75% 68.18% 69.58%
Selling, General & Admin $39.25M $41.84M $23.21M
YoY Change 82.24% 80.26% 128.71%
% of Gross Profit 52.82% 65.51% 47.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $283.0K $304.0K $3.421M
YoY Change 10.12% -91.11% 565.56%
% of Gross Profit 0.38% 0.48% 7.05%
Operating Expenses $108.3M $97.15M $79.07M
YoY Change -5.24% 22.87% 229.51%
Operating Profit -$1.720M -$3.476M -$30.56M
YoY Change -93.61% -88.62% 3878.52%
Interest Expense $7.330M $7.511M -$6.174M
YoY Change -3.35% -221.66% -85.09%
% of Operating Profit
Other Income/Expense, Net $1.257M $1.649M -$1.666M
YoY Change 13866.67% -198.98% -94.66%
Pretax Income -$27.99M -$9.241M -$38.40M
YoY Change 21.42% -75.93% -47.68%
Income Tax $262.0K -$24.00K -$28.42M
% Of Pretax Income
Net Earnings -$27.72M -$9.217M -$9.978M
YoY Change 20.2% -7.63% -86.9%
Net Earnings / Revenue -26.02% -9.84% -14.31%
Basic Earnings Per Share -$2.71 -$1.29 -$0.03
Diluted Earnings Per Share -$2.71 -$1.29 -$43.24K
COMMON SHARES
Basic Shares Outstanding 8.798M 260.0M 230.7M shares
Diluted Shares Outstanding 9.234M 8.652M 7.691M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $96.74M $96.76M $185.0M
YoY Change -37.21% -47.7% 31257.46%
Cash & Equivalents $96.74M $96.76M $249.0M
Short-Term Investments
Other Short-Term Assets $6.278M $8.229M $8.370M
YoY Change -8.43% -1.68% 6875.0%
Inventory
Prepaid Expenses
Receivables $156.6M $148.7M $131.3M
Other Receivables $21.25M $22.96M $14.21M
Total Short-Term Assets $280.9M $276.7M $338.9M
YoY Change -9.91% -18.37% 47636.48%
LONG-TERM ASSETS
Property, Plant & Equipment $2.348M $2.682M $10.86M
YoY Change 14.82% -75.31%
Goodwill $26.72M
YoY Change
Intangibles $185.3M $189.4M
YoY Change -11.46%
Long-Term Investments
YoY Change
Other Assets $50.30M $55.91M $63.98M
YoY Change -20.37% -12.62%
Total Long-Term Assets $237.1M $280.5M $470.3M
YoY Change -49.76% -40.36% 34.27%
TOTAL ASSETS
Total Short-Term Assets $280.9M $276.7M $338.9M
Total Long-Term Assets $237.1M $280.5M $470.3M
Total Assets $517.9M $557.2M $809.2M
YoY Change -33.91% -31.15% 130.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $42.81M $50.29M $43.93M
YoY Change -14.79% 14.48% 12821.47%
Accrued Expenses $8.462M
YoY Change -13.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $51.27M $50.29M $43.93M
YoY Change -14.52% 14.48% 12452.29%
LONG-TERM LIABILITIES
Long-Term Debt $204.0M $208.4M $240.9M
YoY Change -15.43% -13.51%
Other Long-Term Liabilities $17.09M $29.18M $86.30M
YoY Change -75.03% -66.18% 100.51%
Total Long-Term Liabilities $17.09M $29.18M $327.2M
YoY Change -94.48% -91.08% 660.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $51.27M $50.29M $43.93M
Total Long-Term Liabilities $17.09M $29.18M $327.2M
Total Liabilities $264.3M $288.3M $371.1M
YoY Change -28.52% -22.31% 755.37%
SHAREHOLDERS EQUITY
Retained Earnings -$694.4M -$666.7M
YoY Change 38.34%
Common Stock $1.000K $1.000K
YoY Change -95.83%
Preferred Stock
YoY Change
Treasury Stock (at cost) $9.700M $9.700M
YoY Change 0.0%
Treasury Stock Shares $32.33K $32.33K
Shareholders Equity $253.7M $95.49M $438.1M
YoY Change
Total Liabilities & Shareholders Equity $517.9M $557.2M $809.2M
YoY Change -33.91% -31.15% 130.56%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$27.72M -$9.217M -$9.978M
YoY Change 20.2% -7.63% -86.9%
Depreciation, Depletion And Amortization $283.0K $304.0K $3.421M
YoY Change 10.12% -91.11% 565.56%
Cash From Operating Activities $35.36M $2.680M -$8.651M
YoY Change -4216.76% -130.98% -362.87%
INVESTING ACTIVITIES
Capital Expenditures $1.638M $1.037M -$823.0K
YoY Change -174.83% -226.0% 2251.43%
Acquisitions $18.58M
YoY Change
Other Investing Activities -$33.95M -$20.00M -$41.46M
YoY Change 16.77% -51.76% 174.36%
Cash From Investing Activities -$35.59M -$21.03M -$42.28M
YoY Change 13.83% -50.25% 179.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.356M -24.60M 53.69M
YoY Change -2447.19% -145.81% 5.81%
NET CHANGE
Cash From Operating Activities 35.36M 2.680M -8.651M
Cash From Investing Activities -35.59M -21.03M -42.28M
Cash From Financing Activities -8.356M -24.60M 53.69M
Net Change In Cash -8.582M -42.95M 2.763M
YoY Change -72.98% -1654.58% -92.9%
FREE CASH FLOW
Cash From Operating Activities $35.36M $2.680M -$8.651M
Capital Expenditures $1.638M $1.037M -$823.0K
Free Cash Flow $33.73M $1.643M -$7.828M
YoY Change 2435.71% -120.99% -335.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001807846
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-39346
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
MoneyLion Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-0849243
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
30 West 21st Street
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
337000
CY2023Q1 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
119650000
CY2022Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
143394000
CY2023Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
119650000
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
143394000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29184000
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
9th Floor
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10010
CY2023Q1 dei City Area Code
CityAreaCode
(212)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
300-9865
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8798196
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96756000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
115864000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
12302000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
36235000
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
14000000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
37845000
CY2023Q1 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
176211000
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
169976000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27473000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
24841000
CY2023Q1 ml Receivables Net Including Amounts Held By Vi Es
ReceivablesNetIncludingAmountsHeldByVIEs
121734000
CY2022Q4 ml Receivables Net Including Amounts Held By Vi Es
ReceivablesNetIncludingAmountsHeldByVIEs
113963000
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
148738000
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
145135000
CY2023Q1 ml Enterprise Receivables
EnterpriseReceivables
22961000
CY2022Q4 ml Enterprise Receivables
EnterpriseReceivables
19017000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2682000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2976000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
189394000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
194247000
CY2023Q1 us-gaap Goodwill
Goodwill
26721000
CY2022Q4 us-gaap Goodwill
Goodwill
26600000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
55907000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
54658000
CY2023Q1 us-gaap Assets
Assets
557159000
CY2022Q4 us-gaap Assets
Assets
596342000
CY2023Q1 ml Secured Loans
SecuredLoans
88726000
CY2022Q4 ml Secured Loans
SecuredLoans
88617000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
50294000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
58129000
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
486000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33496000
CY2023Q1 us-gaap Liabilities
Liabilities
288340000
CY2022Q4 us-gaap Liabilities
Liabilities
323973000
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
173328000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
173208000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
771881000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
766839000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-666691000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-657979000
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
32333
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
32333
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
9700000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
9700000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
95491000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
99161000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
557159000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
596342000
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
90741000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
67146000
CY2023Q1 ml Interest Income On Loan Net
InterestIncomeOnLoanNet
2928000
CY2022Q1 ml Interest Income On Loan Net
InterestIncomeOnLoanNet
2568000
CY2023Q1 us-gaap Revenues
Revenues
93669000
CY2022Q1 us-gaap Revenues
Revenues
69714000
CY2023Q1 ml Provision For Credit Losses On Consumer Receivables
ProvisionForCreditLossesOnConsumerReceivables
16511000
CY2022Q1 ml Provision For Credit Losses On Consumer Receivables
ProvisionForCreditLossesOnConsumerReceivables
23044000
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
24408000
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
22043000
CY2023Q1 us-gaap Marketing Expense
MarketingExpense
6392000
CY2022Q1 us-gaap Marketing Expense
MarketingExpense
11416000
CY2023Q1 ml Direct Operating Cost
DirectOperatingCost
29802000
CY2022Q1 ml Direct Operating Cost
DirectOperatingCost
21204000
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
4999000
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
7288000
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6038000
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4505000
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-8995000
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-10769000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
97145000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
100269000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3476000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-30555000
CY2023Q1 us-gaap Interest Expense
InterestExpense
7511000
CY2022Q1 us-gaap Interest Expense
InterestExpense
6174000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
149000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3910000
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
246000
CY2022Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-4660000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1649000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-916000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9241000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38395000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-24000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-28417000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-9217000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-9978000
CY2023Q1 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-1977000
CY2022Q1 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-1028000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11194000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11006000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.29
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.29
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.43
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.43
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9805000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2350000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8652218
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8652218
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7691243
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7691243
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
99161000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5705000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-599000
CY2023Q1 ml Issuance Of Common Stock In Connection With Earnout And Makewhole Provisions Related To The
IssuanceOfCommonStockInConnectionWithEarnoutAndMakewholeProvisionsRelatedToThe
1913000
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1977000
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
505000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-9217000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
95491000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
221684000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3268000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
421000
CY2022Q1 ml Issuance Of Common Stock In Connection With Earnout And Makewhole Provisions Related To The
IssuanceOfCommonStockInConnectionWithEarnoutAndMakewholeProvisionsRelatedToThe
10278000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8963000
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1028000
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-127000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9978000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
233481000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-9217000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-9978000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
16511000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
23044000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6184000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3421000
CY2023Q1 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-616000
CY2022Q1 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-259000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
149000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3910000
CY2023Q1 ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-246000
CY2022Q1 ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-4660000
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
7000
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
29000
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-730000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5705000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3268000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-93000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-28442000
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
27000
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
34000
CY2023Q1 ml Increase Decrease In Enterprise Receivables
IncreaseDecreaseInEnterpriseReceivables
4130000
CY2022Q1 ml Increase Decrease In Enterprise Receivables
IncreaseDecreaseInEnterpriseReceivables
-1658000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1250000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-666000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1710000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1672000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2680000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8651000
CY2023Q1 ml Net Originations And Collections Of Finance Receivables
NetOriginationsAndCollectionsOfFinanceReceivables
19647000
CY2022Q1 ml Net Originations And Collections Of Finance Receivables
NetOriginationsAndCollectionsOfFinanceReceivables
22872000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1037000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
823000
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
18584000
CY2023Q1 ml Settlement Of Contingent Consideration Related To Mergers And Acquisitions
SettlementOfContingentConsiderationRelatedToMergersAndAcquisitions
-350000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21034000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-42279000
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
24028000
CY2022Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
375000
CY2023Q1 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-24000000
CY2022Q1 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
10000000
CY2022Q1 ml Borrowings From Secured Lenders
BorrowingsFromSecuredLenders
69300000
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1625000
CY2023Q1 ml Proceeds From Payments For Issuance Of Common Stock Related To Exercise Of Stock Options And Warrants
ProceedsFromPaymentsForIssuanceOfCommonStockRelatedToExerciseOfStockOptionsAndWarrants
-599000
CY2022Q1 ml Proceeds From Payments For Issuance Of Common Stock Related To Exercise Of Stock Options And Warrants
ProceedsFromPaymentsForIssuanceOfCommonStockRelatedToExerciseOfStockOptionsAndWarrants
421000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24599000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
53693000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-42953000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2763000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
153709000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246224000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110756000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
248987000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
7465000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
4990000
CY2023Q1 ml Accrued Dividends On Preferred Stock
AccruedDividendsOnPreferredStock
-1977000
CY2022Q1 ml Accrued Dividends On Preferred Stock
AccruedDividendsOnPreferredStock
-1028000
CY2022Q1 ml Lease Liabilities Incurred In Exchange For Operating Rightofuse Assets
LeaseLiabilitiesIncurredInExchangeForOperatingRightofuseAssets
6578000
CY2023Q1 ml Equity Issued As Consideration For Mergers And Acquisitions
EquityIssuedAsConsiderationForMergersAndAcquisitions
120000
CY2022Q1 ml Equity Issued As Consideration For Mergers And Acquisitions
EquityIssuedAsConsiderationForMergersAndAcquisitions
202610000
CY2023Q1 ml Equity Issued As Settlement Of Contingent Consideration Related To Mergers And Acquisitions
EquityIssuedAsSettlementOfContingentConsiderationRelatedToMergersAndAcquisitions
1913000
CY2022Q1 ml Equity Issued As Settlement Of Contingent Consideration Related To Mergers And Acquisitions
EquityIssuedAsSettlementOfContingentConsiderationRelatedToMergersAndAcquisitions
10278000
CY2022Q1 ml Contingent Consideration Issued Related To Mergers And Acquisitions
ContingentConsiderationIssuedRelatedToMergersAndAcquisitions
45336000
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
At the effective time of the Reverse Stock Split, every 30 shares of Class A Common Stock either issued and outstanding or held as treasury stock were automatically reclassified into one new share of Class A Common Stock, and the total number of shares of Class A Common Stock authorized for issuance was reduced by a corresponding proportion from 2,000,000,000 shares to 66,666,666 shares.
CY2023Q1 us-gaap Conversion Of Stock Type Of Stock Converted
ConversionOfStockTypeOfStockConverted
every 30 shares of Class A Common Stock either issued and outstanding or held as treasury stock were automatically reclassified into one new share of Class A Common Stock
CY2023Q1 ml Service And Subscription Fees
ServiceAndSubscriptionFees
62438000
CY2022Q1 ml Service And Subscription Fees
ServiceAndSubscriptionFees
46394000
CY2023Q1 ml Net Interests Income On Finance Receivables
NetInterestsIncomeOnFinanceReceivables
2928000
CY2022Q1 ml Net Interests Income On Finance Receivables
NetInterestsIncomeOnFinanceReceivables
2568000
CY2023Q1 ml Total Consumer Revenues
TotalConsumerRevenues
65366000
CY2022Q1 ml Total Consumer Revenues
TotalConsumerRevenues
48962000
CY2023Q1 ml Enterprise Service Revenues
EnterpriseServiceRevenues
28303000
CY2022Q1 ml Enterprise Service Revenues
EnterpriseServiceRevenues
20752000
CY2023Q1 us-gaap Revenues
Revenues
93669000
CY2022Q1 us-gaap Revenues
Revenues
69714000
CY2023Q1 ml Fair Value Assets Transfer Amount Between Levels
FairValueAssetsTransferAmountBetweenLevels
0
CY2022Q1 ml Fair Value Assets Transfer Amount Between Levels
FairValueAssetsTransferAmountBetweenLevels
0
CY2023Q1 ml Fair Value Liabilities Transfer Amount Between Levels
FairValueLiabilitiesTransferAmountBetweenLevels
0
CY2022Q1 ml Fair Value Liabilities Transfer Amount Between Levels
FairValueLiabilitiesTransferAmountBetweenLevels
0
CY2023Q1 ml Net Charge Offs Of Accrued Interest Income
NetChargeOffsOfAccruedInterestIncome
307000
CY2022Q1 ml Net Charge Offs Of Accrued Interest Income
NetChargeOffsOfAccruedInterestIncome
548000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2976000
CY2023Q1 us-gaap Depreciation
Depreciation
304000
CY2022Q1 us-gaap Depreciation
Depreciation
230000
CY2023Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
73700000
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
73451000
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
84859000
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
77688000
CY2023Q1 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
158559000
CY2022Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
151139000
CY2023Q1 ml Fees Receivables
FeesReceivables
13292000
CY2022Q4 ml Fees Receivables
FeesReceivables
14019000
CY2023Q1 ml Subscription Receivables
SubscriptionReceivables
3185000
CY2022Q4 ml Subscription Receivables
SubscriptionReceivables
3419000
CY2023Q1 ml Deferred Costs Origination Costs Amount
DeferredCostsOriginationCostsAmount
80000
CY2022Q4 ml Deferred Costs Origination Costs Amount
DeferredCostsOriginationCostsAmount
331000
CY2023Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
1095000
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
1068000
CY2023Q1 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
176211000
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
169976000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5130000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5121000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2448000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2145000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2682000
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
163360000
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
136760000
CY2022Q4 us-gaap Goodwill
Goodwill
26600000
CY2023Q1 ml Goodwill Gross Other Increase Decrease
GoodwillGrossOtherIncreaseDecrease
121000
CY2023Q1 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
121000
CY2023Q1 us-gaap Goodwill Gross
GoodwillGross
163481000
CY2023Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
136760000
CY2023Q1 us-gaap Goodwill
Goodwill
26721000
CY2023Q1 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
38449000
CY2022Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
41495000
CY2023Q1 ml Intangible Assets Work In Progress
IntangibleAssetsWorkInProgress
1551000
CY2022Q4 ml Intangible Assets Work In Progress
IntangibleAssetsWorkInProgress
1812000
CY2023Q1 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
160500000
CY2022Q4 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
160500000
CY2023Q1 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
15960000
CY2022Q4 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
16620000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27066000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
26180000
CY2023Q1 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
189394000
CY2022Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
194247000
CY2023Q1 ml Internally Developed Software Cost Capitalized
InternallyDevelopedSoftwareCostCapitalized
1162000
CY2022Q1 ml Internally Developed Software Cost Capitalized
InternallyDevelopedSoftwareCostCapitalized
758000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5880000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3191000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
17259000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
22925000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
22925000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
22925000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
22353000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
79456000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
187843000
CY2023Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
35280000
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
32881000
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
8229000
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
8804000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8596000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9123000
CY2023Q1 ml Others Accrued Assets
OthersAccruedAssets
3802000
CY2022Q4 ml Others Accrued Assets
OthersAccruedAssets
3850000
CY2023Q1 us-gaap Other Assets
OtherAssets
55907000
CY2022Q4 us-gaap Other Assets
OtherAssets
54658000
CY2023Q1 ml Exceeds Aggregate Principal Amount Percentage
ExceedsAggregatePrincipalAmountPercentage
0.90
CY2023Q1 ml Unamortized Discounts And Debt Issuance Costs
UnamortizedDiscountsAndDebtIssuanceCosts
1274000
CY2022Q4 ml Unamortized Discounts And Debt Issuance Costs
UnamortizedDiscountsAndDebtIssuanceCosts
1383000
CY2023Q1 us-gaap Secured Debt
SecuredDebt
88726000
CY2022Q4 us-gaap Secured Debt
SecuredDebt
88617000
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2350000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2606000
CY2023Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
119650000
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
143394000
CY2023Q1 us-gaap Debt Instrument Description
DebtInstrumentDescription
The interest rate as of March 31, 2023 on the Term A-1 Loans and Term A-2 Loans was 14.07% and 13.75%, respectively.
CY2023Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2023Q1 us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
796000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
620000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2483000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3116000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2670000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1268000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
904000
CY2023Q1 ml Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
768000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11209000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2139000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
9070000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.118
CY2023Q1 us-gaap Deferred Taxes Business Combination Valuation Allowance Available To Reduce Goodwill And Intangible Assets
DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceGoodwillAndIntangibleAssets
86120000
CY2022Q4 us-gaap Deferred Taxes Business Combination Valuation Allowance Available To Reduce Goodwill And Intangible Assets
DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceGoodwillAndIntangibleAssets
84952000
CY2023Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1200000
CY2022Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-17100000
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
787000000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
786600000
CY2023Q1 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
1200000
CY2023Q1 ml Current Carryforwards Expiration Term
CurrentCarryforwardsExpirationTerm
If not used, the current carryforwards will expire beginning in 2034.
CY2022Q1 ml Annual Limitation Amount Per Year
AnnualLimitationAmountPerYear
8200000
CY2022Q1 ml Net Unrealized Built In Gains
NetUnrealizedBuiltInGains
330700000
CY2023Q1 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Company's annual limitation is expected to be increased in the first five years
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
121400000
CY2023Q1 ml Net Operating Losses Subject To Limitation
NetOperatingLossesSubjectToLimitation
3800000
CY2023Q1 ml Net Unrealized Built In Gains
NetUnrealizedBuiltInGains
265200000
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
87800000
CY2023Q1 ml Net Operating Losses Available
NetOperatingLossesAvailable
3100000
CY2023Q1 ml Net Operating Losses Restricted
NetOperatingLossesRestricted
6000000
CY2023Q1 ml Net Operating Losses Generated
NetOperatingLossesGenerated
55000000
CY2023Q1 ml Net Operating Loss Carryforwards Solely Subject To Limitation
NetOperatingLossCarryforwardsSolelySubjectToLimitation
58100000
CY2023Q1 ml Net Operating Losses Restricted
NetOperatingLossesRestricted
6000000
CY2023Q1 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
CY2023Q1 us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
Shares of Series A Preferred Stock are convertible into shares of Class A Common Stock on a one-for-thirty basis, subject to customary anti-dilution adjustments.
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5705000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3268000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-9217000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-9978000
CY2023Q1 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-1977000
CY2022Q1 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-1028000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11194000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11006000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8652218
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8652218
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7691243
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7691243
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.29
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.29
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.43
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.43
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4931647
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4566247
CY2023Q1 ml Cash Paid To Equityholders
CashPaidToEquityholders
14514000
CY2023Q1 ml Shares Exchange
SharesExchange
8883228
CY2023Q1 ml Common Stock Option To Acquire
CommonStockOptionToAcquire
196728
CY2023Q1 ml Common Stock Value Vested Option
CommonStockValueVestedOption
8960000
CY2023Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8000000
CY2023Q1 ml Earnout And Preferred Stock Equivalents Value
EarnoutAndPreferredStockEquivalentsValue
45330000
CY2023Q1 ml Business Combination Purchase Price Value
BusinessCombinationPurchasePriceValue
271096000
CY2023Q1 us-gaap Capital Units
CapitalUnits
5703000
CY2023Q1 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
2868000
CY2023Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
78813000
CY2023Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-14347000
CY2023Q1 ml Sellers Earning Payable In Restricted Share
SellersEarningPayableInRestrictedShare
35000000
CY2022Q4 ml Unsettled Restricted Shares Payable
UnsettledRestrictedSharesPayable
2444000
CY2023Q1 us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
-180000
CY2022Q1 us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
4292000
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
At the effective time of the Reverse Stock Split, every 30 shares of Class A Common Stock either issued and outstanding or held as treasury stock were automatically reclassified into one new share of Class A Common Stock, and the total number of shares of Class A Common Stock authorized for issuance was reduced by a corresponding proportion from 2,000,000,000 shares to 66,666,666 shares.
CY2023Q1 us-gaap Conversion Of Stock Type Of Stock Converted
ConversionOfStockTypeOfStockConverted
every 30 shares of Class A Common Stock either issued and outstanding or held as treasury stock were automatically reclassified into one new share of Class A Common Stock

Files In Submission

Name View Source Status
ml-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0000950170-23-019672-index-headers.html Edgar Link pending
0000950170-23-019672-index.html Edgar Link pending
0000950170-23-019672.txt Edgar Link pending
0000950170-23-019672-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ml-20230331.htm Edgar Link pending
ml-20230331.xsd Edgar Link pending
ml-ex10_1.htm Edgar Link pending
ml-ex31_1.htm Edgar Link pending
ml-ex31_2.htm Edgar Link pending
ml-ex32_1.htm Edgar Link pending
ml-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
ml-20230331_def.xml Edgar Link unprocessable
ml-20230331_cal.xml Edgar Link unprocessable
ml-20230331_lab.xml Edgar Link unprocessable
ml-20230331_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending